Bisoprolol: Pharmacokinetic profile

Reviews in Contemporary Pharmacotherapy

Volumn 8, Issue 1, 1997, Pages 35-43

  Leopold, Götz ^a   Kutz, Klaus ^a  

^a Research and Development   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BISOPROLOL; CIMETIDINE; RIFAMPICIN;

ADULT; AGED; ANURIA; DISEASE SEVERITY; DOSE RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; DRUG PROTEIN BINDING; GERIATRICS; HUMAN; HYPERTHYROIDISM; KIDNEY CLEARANCE; KIDNEY FAILURE; LIVER FAILURE; NORMAL HUMAN; REVIEW;

EID: 0030970891     PISSN: 09548602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Beal SL, Sheiner LB. NONMEM user's guide parts I to VI. San Francisco, CA: Division of Clinical Pharmacology, University of California, 1980.
2. Bennett PN, John VA, Whitmarsh VB. Effect of rifampicin on metoprolol and antipyrine kinetics. Br J Clin Pharmacol 1982; 13: 387-391.
3. Bühring KU, Garbc A. Determination of the new β-blocker bisoprolol and of metoprolol, atenolol and propranolol in plasma and urine by high performance liquid chromatography. J Chromatogr/Biomed Appl 1986; 382: 215-224.
4. 14C in three animal species and in humans. J Cardiovasc Pharmacol 1986: 8(Suppl 11): S21-S28.
5. Cheung WK, Begg E, Dutta A et al. Dose proportionality of bisoprolol in man. Pharm Res 1988; 5 (Suppl): S159.
6. Dutta A, Cheung WK, Greene DS et al. Pharmacokinetics of bisoprolol in the fasted and fed state. Pharm Res 1988; 5 (Suppl): S169.
7. Dutta A, Lane R, Begg E et al. Dose proportionality of bisoprolol enantiomcrs in humans after oral administration of the racemate. J Clin Pharmacol 1994; 34: 829-836.
8. Feely J, Wilkinson GR, Wood AJJ. Reduction of liver blood flow and propranolol metabolism by cimetidine. N Engl J Med 1981; 304: 692-695.
9. Gibaldi M, Perrier D. Pharmacokinetics, 2nd edn. New York: Marcel Dekker, 1982.
10. Grevel J, Thomas P, Whiting B. Population pharmacokinetics of bisoprolol. Clin Pharmacokinet 1989; 17: 53-63.
11. Hayes PC, Jenkins D, Vavianos P et al. Single oral dose pharmacokinetics of bisoprolol 10 mg in liver disease. Eur Heart J 1987; 8 (Suppl M): 23-29.
12. Herman RJ, Nakamura K, Wilkinson GR, Wood AJJ. Induction of propranolol metabolism by rifampicin. Pharmacologist 1982; 24: 181.
13. Kirch W, Köhler H, Spahn H, Mutschler E. Interaction of cimetidine with metoprolol, propranolol or atenolol. Lancet 1981; ii: 531-532.
14. Kirch W, Rose I, Klingmann I, Pabst J, Ohnhaus EE. Interaction of bisoprolol with cimetidine and rifampicin. Eur J Clin Pharmacol 1986; 31: 59-62.
15. Kirch W, Rose I, Demers HG, Leopold G, Pabst J, Ohnhaus EE. Pharmacokinetics of bisoprolol during repeated oral administration to healthy volunteers and patients with kidney or liver disease. Clin Pharmacokinet 1987; 13: 110-117.
16. Leopold G. Balanced pharmacokinetics and metabolism of bisoprolol. J Cardiovasc Pharmacol 1986; 8 (Suppl 11): S16-S20.
17. Leopold G. Discussion session 2. Eur Heart J 1987; 8 (Suppl M): 147-148.
18. 1-selective adrenoceptor antagonist. J Clin Pharmacol 1986; 26: 616-621.
19. 3H (±) carazolol binding to β-adrenergic receptors. Circ Res 1982; 49: 326-336.
20. Muralidharan G, Faulkner R, Akester J et al. Pharmacokinetics (PK) of bisoprolol (B) and hydrochlorthiazide (HCTZ) in healthy volunteers after administration of low dose combinations of B/HCTZ (2.5/6.25 mg and 5.0/6.25 mg). Pharm Res 1992; 9 (Suppl): S321.
21. Palm D, Wellstein A, Belz GG, Butzer R. Beta-Rezeptorenblockade. Therapiewoche 1988; 38: 3339-3345.
22. Payton CD, Fox JG, Pauleau NF et al. The single dose pharmacokinetics of bisoprolol (10 mg) in renal insufficiency: the clinical significance of balanced clearance. Eur Heart J 1987; 8 (Suppl): 15-22.
23. Pfannenstiel P, Rummeny E, Baew-Christow Th et al. Pharmacokinetics of bisoprolol and influence on serum thyroid hormones in hyperthyroid patients. J Cardiovasc Pharmacol 1986; 8 (Suppl 11): 100-105.
24. Pugh RNH, Murray-Lyon IM, Dawson JL, Pretroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646-649.
25. 1-selectivity of bisoprolol, a new β-adrenoceptor antagonist, in anesthetized dogs and guinea pigs. J Cardiovasc Pharmacol 1984; 6: 1156-1160.
26. Vechlekar DL, Cheung WK, Pearse S et al. Bisoprolol does not alter the pharmacokinetics of digoxin. Pharm Res 1988; 5 (Suppl): S176.
27. Verrostte JM, van Hemel NM, Kingma JH. Interaction of bisoprolol and procainamide in human cardiac impulse generation and conduction. J Cardiovasc Pharmacol 1990; 16 (Suppl 5): S193-S195.
28. Warrington SJ, Johnston A, Lewis Y, Murphy M. Bisoprolol: studies of potential interactions with theophylline and warfarin in healthy volunteers. J Cardiovasc Pharmacol 1990; 16 (Suppl 5): S164-S168.
29. Wellstein A, Palm D, Belz GG, Butzer R, Polsak R, Pett B. Reduction of exercise tachycardia in man after propranolol, atenolol and bisoprolol in comparison to beta-adrenoceptor occupancy. Eur Heart J 1987; 8 (Suppl M): 3-8.